Similar articles

• Risk management in a polio-free world.

  Bruce Aylward R, Sutter RW, Cochi SL, Thompson KM, Jafari H, Heymann D. Bruce Aylward R, et al. Risk Anal. 2006 Dec;26(6):1441-8. doi: 10.1111/j.1539-6924.2006.00840.x. Risk Anal. 2006. PMID: 17184391 Review.
• Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.

  [No authors listed] [No authors listed] Wkly Epidemiol Rec. 2014 Mar 21;89(12):127-32. Wkly Epidemiol Rec. 2014. PMID: 24707518 English, French. No abstract available.
• [End phase challenges of poliomyelitis eradication programme realization].

  Jarzabek Z. Jarzabek Z. Przegl Epidemiol. 2005;59(1):59-68. Przegl Epidemiol. 2005. PMID: 16013411 Review. Polish.
• [Worldwide eradication of poliomyelitis].

  Rasch G, Schreier E, Kiehl W, Kurth R. Rasch G, et al. Wien Klin Wochenschr. 2001 Oct 30;113(20-21):839-45. Wien Klin Wochenschr. 2001. PMID: 11732120 Review. German.
• Poliomyelitis vaccines in Belgium: 20 years of experience.

  Andre FE. Andre FE. Dev Biol Stand. 1979;43:187-93. Dev Biol Stand. 1979. PMID: 230109 No abstract available.